Australija - engleski - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - remifentanil hydrochloride, quantity: 2.194 mg (equivalent: remifentanil, qty 2 mg) - injection, powder for - excipient ingredients: glycine - ultiva for injection is indicated- as an opioid adjunct for use during induction and/or maintenance of general anaesthesia during surgical procedures including cardiac surgery in adults; as an opioid adjunct for use during induction and/or maintenance of general anaesthesia during surgical but not cardiac procedures in children aged 1 to 12 years; for continuation as an analgesic into the immediate post-operative period under the close supervision of medically qualified persons trained in the use of anaesthetic drugs, during transition to longer acting analgesia following adult cardiac surgery-when endotracheal intubation and controlled ventillation are anticipated. for provision of analgesia and sedation in mechanically ventilated intensive care patients.

Australija - engleski - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - remifentanil hydrochloride, quantity: 1.097 mg (equivalent: remifentanil, qty 1 mg) - injection, powder for - excipient ingredients: glycine - ultiva for injection is indicated- as an opioid adjunct for use during induction and/or maintenance of general anaesthesia during surgical procedures including cardiac surgery in adults; as an opioid adjunct for use during induction and/or maintenance of general anaesthesia during surgical but not cardiac procedures in children aged 1 to 12 years; for continuation as an analgesic into the immediate post-operative period under the close supervision of medically qualified persons trained in the use of anaesthetic drugs, during transition to longer acting analgesia following adult cardiac surgery-when endotracheal intubation and controlled ventillation are anticipated. for provision of analgesia and sedation in mechanically ventilated intensive care patients.

Australija - engleski - Department of Health (Therapeutic Goods Administration)

merck sharp & dohme (australia) pty ltd - rocuronium bromide, quantity: 10 mg/ml - injection, solution - excipient ingredients: sodium chloride; water for injections; glacial acetic acid; sodium acetate trihydrate - rocuronium is indicated as an adjunct to general anaesthesia to facilitate endotracheal intubation during routine induction, to provide muscle relaxation and to facilitate mechanical ventilation in adults, and paediatric patients from term newborn infants to adolescents.,in adults, rocuronium is also indicated as an adjunct to general anaesthesia to facilitate endotracheal,intubation during rapid sequence induction when suxamethonium is contraindicated. in adults, rocuronium is also indicated as an adjunct in the intensive care unit (icu) to facilitate mechanical ventilation.

Australija - engleski - Department of Health (Therapeutic Goods Administration)

specialites septodont pty ltd - mepivacaine hydrochloride, quantity: 20 mg/ml; adrenaline (epinephrine), quantity: 0.01 mg/ml - injection, solution - excipient ingredients: water for injections; sodium chloride; potassium metabisulfite; disodium edetate; hydrochloric acid; sodium hydroxide - indications as at may 2003: scandonest 2% special is recommended for oral surgery requiring prolonged duration of anaesthesia and haemostasis.

Australija - engleski - Department of Health (Therapeutic Goods Administration)

specialites septodont pty ltd - mepivacaine hydrochloride, quantity: 20 mg/ml; adrenaline (epinephrine), quantity: 0.01 mg/ml - injection, solution - excipient ingredients: water for injections; sodium chloride; potassium metabisulfite; disodium edetate; hydrochloric acid; sodium hydroxide - indications as at may 2003: scandonest 2% special is recommended for oral surgery requiring prolonged duration of anaesthesia and haemostasis.

Australija - engleski - Department of Health (Therapeutic Goods Administration)

specialites septodont pty ltd - mepivacaine hydrochloride, quantity: 30 mg/ml - injection, solution - excipient ingredients: sodium chloride; sodium hydroxide; water for injections - indications as at may 2003: scandonest 3% is indicated for the production of local anaesthesia in routine dental procedures and oral surgery by means of infiltration and nerve block techniques.

Australija - engleski - Department of Health (Therapeutic Goods Administration)

specialites septodont pty ltd - mepivacaine hydrochloride, quantity: 30 mg/ml - injection, solution - excipient ingredients: sodium chloride; sodium hydroxide; water for injections - indications as at may 2003: scandonest 3% is indicated for the production of local anaesthesia in routine dental procedures and oral surgery by means of infiltration and nerve block techniques.

Australija - engleski - Department of Health (Therapeutic Goods Administration)

dentsply sirona pty ltd - adrenaline (epinephrine) acid tartrate, quantity: 22.7 microgram/ml (equivalent: adrenaline (epinephrine), qty 12.5 microgram/ml); lidocaine hydrochloride monohydrate, quantity: 21.3 mg/ml (equivalent: lidocaine hydrochloride, qty 20 mg/ml) - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; water for injections; sodium metabisulfite; sodium hydroxide - indications as at 25 july 2003 : lidocaine (lignocaine) solutions are indicated for the production of local anaesthesia in routine dental procedures and oral surgery by means of infiltration and nerve block techniques. lidocaine (lignocaine) solutions with adrenaline (epinephrine) are recommended for oral surgery requiring prolonged duration of anaesthesia and haemostasis.

Australija - engleski - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - isoprenaline hydrochloride, quantity: 1 mg - injection, solution - excipient ingredients: disodium edetate; sodium chloride; sodium citrate dihydrate; citric acid; hydrochloric acid; sodium hydroxide; water for injections - cipla isoprenaline is indicated: - for mild or transient episodes of heart block that do not require electric shock or pacemaker therapy. - for serious episodes of heart block and adams-stokes attacks (except when caused by ventricular tachycardia or fibrillation) (see section 4.3 contraindications). - for use in cardiac arrest until electric shock or pacemaker therapy, the treatments of choice, are available (see section 4.3 contraindications). - for brochospasm occurring during anaesthesia. - as an adjunct to fluid and electrolyte replacement therapy and the use of other drugs and procedures in the treatment of hypovolaemic and septic shock, low cardiac output (hypoperfusion) states, congestive heart failure and cariodgenic shock (see section 4.4 special warnings and precautions for use).

Australija - engleski - Department of Health (Therapeutic Goods Administration)

medsurge pharma pty ltd - isoprenaline hydrochloride, quantity: 1 mg - injection, solution - excipient ingredients: sodium hydroxide; water for injections; hydrochloric acid; sodium chloride; disodium edetate; sodium citrate dihydrate; citric acid - isoprenaline hydrochloride is indicated: for mild or transient episodes of heart block that do not require electric shock or pacemaker therapy.,for serious episodes of heart block and adams-stokes attacks (except when caused by ventricular tachycardia or fibrillation). (see section 4.3 contraindications),for use in cardiac arrest until electric shock or pacemaker therapy, the treatments of choice, are available. (see section 4.3 contraindications.),for bronchospasm occurring during anaesthesia.,as an adjunct to fluid and electrolyte replacement therapy and the use of other drugs and procedures in the treatment of hypovolaemic and septic shock, low cardiac output (hypoperfusion) states, congestive heart failure and cardiogenic shock. (see section 4.4 special warnings and precautions for use).